McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan authored an article entitled, “TPP abandonment: the fallout for biotech and pharma” that appears in the March 15, 2017 online edition of Life Sciences Intellectual Property Review. President Trump’s decision to pull the US out of the Trans-Pacific Partnership trade deal may have particularly pernicious consequences for the pharmaceutical and biotechnology industries. View the article